Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma

Purpose: Radiotherapy (RT) has long been and remains the only treatment option for diffuse intrinsic pontine glioma (DIPG). However, all patients show evidence of disease progression within months of completing RT. No further clinical benefit has been achieved using alternative radiation strategies. Here, we tested the hypothesis that histone demethylase inhibition by GSK-J4 enhances radiation-induced DNA damage, making it a potential radiosensitizer in the treatment of DIPG. Experimental Design: We evaluated the effects of GSK-J4 on genes associated with DNA double-strand break (DSB) repair in DIPG cells by RNA sequence, ATAC sequence, and quantitative real-time PCR. Radiation-induced DNA DSB repair was analyzed by immunocytochemistry of DSB markers γH2AX and 53BP1, DNA-repair assay, and cell-cycle distribution. Clonogenic survival assay was used to determine the effect of GSK-J4 on radiation response of DIPG cells. In vivo response to radiation monotherapy and combination therapy of RT and GSK-J4 was evaluated in patient-derived DIPG xenografts. Results: GSK-J4 significantly reduced the expression of DNA DSB repair genes and DNA accessibility in DIPG cells. GSK-J4 sustained high levels of γH2AX and 53BP1 in irradiated DIPG cells, thereby inhibiting DNA DSB repair through homologous recombination pathway. GSK-J4 reduced clonogenic survival and enhanced radiation effect in DIPG cells. In vivo studies revealed increased survival of animals treated with combination therapy of RT and GSK-J4 compared with either monotherapy. Conclusions: Together, these results highlight GSK-J4 as a potential radiosensitizer and provide a rationale for developing combination therapy with radiation in the treatment of DIPG.

[1]  T. Yi,et al.  Comprehensive profiling of JMJD3 in gastric cancer and its influence on patient survival , 2019, Scientific Reports.

[2]  Krista M. Powell,et al.  Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma , 2018, Science Translational Medicine.

[3]  A. Sengupta,et al.  KDM6 and KDM4 histone lysine demethylases emerge as molecular therapeutic targets in human acute myeloid leukemia. , 2017, Experimental hematology.

[4]  S. Mueller,et al.  New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model , 2018, Journal of Neuro-Oncology.

[5]  Y. Li,et al.  Inhibitor of H3K27 demethylase JMJD3/UTX GSK-J4 is a potential therapeutic option for castration resistant prostate cancer , 2017, Oncotarget.

[6]  E. Maury,et al.  Epigenetic modification in chromatin machinery and its deregulation in pediatric brain tumors: Insight into epigenetic therapies , 2017, Epigenetics.

[7]  B. Price,et al.  Epigenetic therapy with inhibitors of histone methylation suppresses DNA damage signaling and increases glioma cell radiosensitivity , 2017, Oncotarget.

[8]  R. Davis,et al.  Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs , 2017, Haematologica.

[9]  N. Gupta,et al.  Patient-derived Tumor Models for Diffuse Intrinsic Pontine Gliomas , 2016, Current neuropharmacology.

[10]  M. Prados,et al.  Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth. , 2016, Neuro-oncology.

[11]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[12]  Nicholas J. Wang,et al.  Functionally-defined Therapeutic Targets in Diffuse Intrinsic Pontine Glioma , 2015, Nature Medicine.

[13]  D. Roos,et al.  Randomized trial on radiotherapy for paediatric diffuse intrinsic pontine glioma (DIPG). , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[15]  C. James,et al.  Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma , 2014, Nature Medicine.

[16]  Jill S. Barnholtz-Sloan,et al.  Childhood Brain Tumor Epidemiology: A Brain Tumor Epidemiology Consortium Review , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[17]  R. Jaenisch,et al.  Contrasting roles for histone 3 lysine 27 demethylases in acute lymphoblastic leukemia , 2014, Nature.

[18]  K. Helin,et al.  The Histone Lysine Demethylase JMJD3/KDM6B Is Recruited to p53 Bound Promoters and Enhancer Elements in a p53 Dependent Manner , 2014, PloS one.

[19]  M. Kieran,et al.  Diffuse intrinsic pontine glioma: a reassessment , 2014, Journal of Neuro-Oncology.

[20]  M. Berger,et al.  Targeting Wee1 for the treatment of pediatric high-grade gliomas. , 2014, Neuro-oncology.

[21]  David T. W. Jones,et al.  Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. , 2013, Cancer cell.

[22]  M. Lomax,et al.  Biological consequences of radiation-induced DNA damage: relevance to radiotherapy. , 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

[23]  G. Poirier,et al.  Polycomb repressive complex 2 contributes to DNA double-strand break repair , 2013, Cell cycle.

[24]  B. Garcia,et al.  Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma , 2013, Science.

[25]  Sabine Mueller,et al.  The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression. , 2013, Genes & development.

[26]  V. Marquez,et al.  Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells. , 2013, Neuro-oncology.

[27]  K. Warren.  Diffuse intrinsic pontine glioma: poised for progress , 2012, Front. Oncol..

[28]  M. Prados,et al.  Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment , 2012, Journal of Neuro-Oncology.

[29]  Christopher J. Schofield,et al.  A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response , 2012, Nature.

[30]  E. Greer,et al.  Histone methylation: a dynamic mark in health, disease and inheritance , 2012, Nature Reviews Genetics.

[31]  L. Zitvogel,et al.  Inflammasomes in carcinogenesis and anticancer immune responses , 2012, Nature Immunology.

[32]  L. Ketonen,et al.  Palliative Reirradiation for Progressive Diffuse Intrinsic Pontine Glioma , 2012, American journal of clinical oncology.

[33]  M. Prados,et al.  An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing , 2012, Journal of Neuro-Oncology.

[34]  S. Baylin,et al.  Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands. , 2011, Cancer cell.

[35]  S. Elledge,et al.  A chromatin localization screen reveals poly (ADP ribose)-regulated recruitment of the repressive polycomb and NuRD complexes to sites of DNA damage , 2010, Proceedings of the National Academy of Sciences.

[36]  Andrei Seluanov,et al.  Analysis of DNA double-strand break (DSB) repair in mammalian cells. , 2010, Journal of visualized experiments : JoVE.

[37]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[38]  S. Baylin,et al.  Double Strand Breaks Can Initiate Gene Silencing and SIRT1-Dependent Onset of DNA Methylation in an Exogenous Promoter CpG Island , 2008, PLoS genetics.

[39]  P. Sung,et al.  Mechanism of eukaryotic homologous recombination. , 2008, Annual review of biochemistry.

[40]  M. Lieber,et al.  The Mechanism of Human Nonhomologous DNA End Joining* , 2008, Journal of Biological Chemistry.

[41]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. Ball,et al.  Statistics review 12: Survival analysis , 2004, Critical care.

[43]  Kai Rothkamm,et al.  Pathways of DNA Double-Strand Break Repair during the Mammalian Cell Cycle , 2003, Molecular and Cellular Biology.

[44]  Amar Gajjar,et al.  Decline in corpus callosum volume among pediatric patients with medulloblastoma: longitudinal MR imaging study. , 2002, AJNR. American journal of neuroradiology.

[45]  B. Moore,et al.  Neurophysiological basis of cognitive deficits in long-term survivors of childhood cancer. , 1992, Archives of neurology.

[46]  R. Brauner,et al.  Growth and Endocrine Disorders Secondary to Cranial Irradiation , 1989, Pediatric Research.

[47]  S. Holm.  A Simple Sequentially Rejective Multiple Test Procedure , 1979 .